FCCC (OTCMKTS:FCIC) and Global Cord Blood (NYSE:CO) are both small-cap finance companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, earnings, analyst recommendations, dividends, profitability, institutional ownership and valuation.

Institutional and Insider Ownership

16.0% of Global Cord Blood shares are held by institutional investors. 29.2% of FCCC shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Risk & Volatility

FCCC has a beta of 1.91, meaning that its share price is 91% more volatile than the S&P 500. Comparatively, Global Cord Blood has a beta of 0.48, meaning that its share price is 52% less volatile than the S&P 500.


This table compares FCCC and Global Cord Blood’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
FCCC N/A -41.27% -38.24%
Global Cord Blood 24.77% 7.53% 4.00%

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for FCCC and Global Cord Blood, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
FCCC 0 0 0 0 N/A
Global Cord Blood 0 0 0 0 N/A


Global Cord Blood pays an annual dividend of $0.08 per share and has a dividend yield of 1.4%. FCCC does not pay a dividend.

Earnings & Valuation

This table compares FCCC and Global Cord Blood’s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
FCCC N/A N/A -$70,000.00 N/A N/A
Global Cord Blood $149.34 million 4.76 $37.79 million N/A N/A

Global Cord Blood has higher revenue and earnings than FCCC.


Global Cord Blood beats FCCC on 7 of the 9 factors compared between the two stocks.

About FCCC

FCCC, Inc. does not have significant operations. The company is seeking for a merger, acquisition, reverse merger, or business combination with an operating business or other appropriate financial transaction. Previously, it was engaged in the mortgage loan business. The company was formerly known as The First Connecticut Capital Corporation and changed its name to FCCC, Inc. in June 2003. FCCC, Inc. was incorporated in 1960 and is based in Carmel, Indiana.

About Global Cord Blood

Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2018, it had three operating cord blood banks in the Beijing municipality, the Guangdong province, and the Zhejiang province. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation is a subsidiary of Nanjing Ying Peng Hui Kang Medical Industry Investment Partnership (Limited Partnership).

Receive News & Ratings for FCCC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for FCCC and related companies with MarketBeat.com's FREE daily email newsletter.